UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature

Infection, 2018-06, Vol.46 (3), p.409-418

2018

Volltextzugriff (PDF)

P584: OVERALL SURVIVAL WITH INTENSIVE CHEMOTHERAPY (IC) VS NON‐IC IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AML FROM THE CONNECT® MYELOID DISEASE REGISTRY INELIGIBLE FOR RANDOMIZED CLINICAL TRIALS (RCT)

HemaSphere, 2022-06, Vol.6, p.483-484

2022

Volltextzugriff (PDF)

Phase I Study of Temozolomide in Relapsed/Refractory Acute Leukemia

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3249-3253

2002

Volltextzugriff (PDF)

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

Leukemia, 2003-02, Vol.17 (2), p.314-318

2003

Volltextzugriff (PDF)

EE86 Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients with Acute Myeloid Leukemia (AML) Treated with Oral Azacitidine as Maintenance and Those Eligible but Not Treated Using a US Claims Database

Value in health, 2023-12, Vol.26 (12), p.S67

2023

Volltextzugriff (PDF)

Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate

Leukemia, 2007-03, Vol.21 (3), p.577-578

2007

Volltextzugriff (PDF)

The Differentiation and Maturation Mediator for Human Myeloid Leukemia Cells Shares Homology With Neuroleukin or Phosphoglucose Isomerase

Blood, 1996-06, Vol.87 (11), p.4502-4506

1996

Volltextzugriff (PDF)

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

Haematologica (Roma), 2016-05, Vol.101 (5), p.e185

2016

Volltextzugriff (PDF)

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4207-4213

2010

Volltextzugriff (PDF)

SAFETY AND TOLERABILITY OF MYELOABLATIVE CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOLLOWED BY POLATUZUMAB VEDOTIN (PV) IMMNOCONJUGATE THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

Leukemia research, 2022-10, Vol.121, p.S24-S25

2022

Volltextzugriff (PDF)

033 - SAFETY AND TOLERABILITY OF MYELOABLATIVE CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOLLOWED BY POLATUZUMAB VEDOTIN (PV) IMMNOCONJUGATE THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

Leukemia research, 2022-10, Vol.121, p.S24-S25

2022

Volltextzugriff (PDF)

Successful treatment of a desmoid tumor with doxorubicin

Cancer, 1993-04, Vol.71 (7), p.2242-2244

1993

Volltextzugriff (PDF)

Benthic carbon mineralization on a global scale

Global biogeochemical cycles, 2005-03, Vol.19 (1), p.GB1010-n/a

2005

Volltextzugriff (PDF)

Induction of apoptosis by topotecan: implications for the treatment of leukemia

Seminars in hematology, 1998-07, Vol.35 (3 Suppl 4), p.22

Seiter, K

1998

Volltextzugriff (PDF)

Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia

Clinical interventions in aging, 2015-01, Vol.10, p.951-961

2015

Volltextzugriff (PDF)

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

Leukemia, 2001-06, Vol.15 (6), p.963-970

2001

Volltextzugriff (PDF)

Organic carbon content in surface sediments—defining regional provinces

Deep-sea research. Part I, Oceanographic research papers, 2004-12, Vol.51 (12), p.2001-2026

2004

Volltextzugriff (PDF)

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia

Leukemia, 1996-01, Vol.10 (1), p.40

1996

Volltextzugriff (PDF)

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2480-2485

1996

Volltextzugriff (PDF)

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

Leukemia & lymphoma, 2004-11, Vol.45 (11), p.2253-2259

2004

Volltextzugriff (PDF)

Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant

Leukemia & lymphoma, 2005-03, Vol.46 (3), p.405-414

2005

Volltextzugriff (PDF)

PCN98 - Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States

Value in health, 2018-05, Vol.21, p.S28-S28

2018

Volltextzugriff (PDF)

Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States

Value in health, 2018-05, Vol.21, p.S28

2018

Volltextzugriff (PDF)

In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis

Journal of clinical pathology, 2004-05, Vol.57 (5), p.499-503

2004

Volltextzugriff (PDF)

Josef Pieper and the Danger of Sophistry

Seiter, Joseph K

2024

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(173)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(101)
Humans
(92)
Male
(57)
Female
(51)
Oncology
(51)
Biological And Medical Sciences
(47)
Middle Aged
(47)
Adult
(45)
Medical Sciences
(42)
Aged
(40)
Hematology
(38)
Chemotherapy
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Pharmacology. Drug Treatments
(22)
Animals
(20)
Treatment Outcome
(20)
Antineoplastic Agents
(17)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(17)
Aged, 80 And Over
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature

P584: OVERALL SURVIVAL WITH INTENSIVE CHEMOTHERAPY (IC) VS NON‐IC IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AML FROM THE CONNECT® MYELOID DISEASE REGISTRY INELIGIBLE FOR RANDOMIZED CLINICAL TRIALS (RCT)

Phase I Study of Temozolomide in Relapsed/Refractory Acute Leukemia

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

EE86 Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients with Acute Myeloid Leukemia (AML) Treated with Oral Azacitidine as Maintenance and Those Eligible but Not Treated Using a US Claims Database

Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate

The Differentiation and Maturation Mediator for Human Myeloid Leukemia Cells Shares Homology With Neuroleukin or Phosphoglucose Isomerase

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

SAFETY AND TOLERABILITY OF MYELOABLATIVE CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOLLOWED BY POLATUZUMAB VEDOTIN (PV) IMMNOCONJUGATE THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

033 - SAFETY AND TOLERABILITY OF MYELOABLATIVE CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOLLOWED BY POLATUZUMAB VEDOTIN (PV) IMMNOCONJUGATE THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

Successful treatment of a desmoid tumor with doxorubicin

Benthic carbon mineralization on a global scale

Induction of apoptosis by topotecan: implications for the treatment of leukemia

Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

Organic carbon content in surface sediments—defining regional provinces

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant

PCN98 - Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States

Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United States

In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis

Josef Pieper and the Danger of Sophistry

Suchergebnisse filtern